{
    "Trade/Device Name(s)": [
        "BD Phoenix\u2122M Automated Microbiology System - Daptomycin (0.0313-16 \u03bcg/mL)",
        "BD Phoenix\u2122 Automated Microbiology System Daptomycin (0.03-16 \u03bcg/mL) - streptococcus ID/AST or AST only Phoenix Panels"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K073589",
    "Predicate Device Reference 510(k) Number(s)": [
        "N50510",
        "K020321",
        "K060324",
        "K020323",
        "K020322"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "March 5, 2008",
    "Summary Letter Received Date": "December 20, 2007",
    "Submission Date": "December 19, 2007",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility Devices"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Daptomycin"
    ],
    "Specimen Type(s)": [
        "Pure culture of aerobic and facultative anaerobic Gram-negative and Gram-positive bacteria isolates",
        "Streptococcus agalactiae",
        "Streptococcus dysgalactiae",
        "Streptococcus pyogenes"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Broth microdilution",
        "Automated susceptibility testing",
        "Redox indicator detection"
    ],
    "Methodologies": [
        "Quantitative antimicrobial susceptibility testing (MIC determination)",
        "Microdilution"
    ],
    "Submission Type(s)": [
        "System",
        "Panel",
        "Analyzer",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix\u2122M Automated Microbiology System using daptomycin panels for rapid identification and susceptibility testing of Streptococcus isolates",
    "Indications for Use Summary": "Intended for in vitro quantitative determination of antimicrobial susceptibility by minimal inhibitory concentration (MIC) of Gram-negative and Gram-positive bacteria, including Staphylococcus, Enterococcus, and Streptococcus, from pure cultures using daptomycin panels",
    "fda_folder": "Microbiology"
}